Advertisement
Dr. Renier Brentjens, MD, PhD from the Memorial Sloan Kettering Cancer Center, discusses the goal of armored CAR T-cells. He talks about how the researchers add additional genets to the T-cells that allow them to function better when infused back into the patient. These are the “next generation” of CAR T-cells to overcome the current limitations of the technology. They are called “armored” CAR T-cells.
